Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.
The rapid evolution of new sublineages of H5N1 influenza poses the greatest challenge in control of H5N1 infection by currently existing vaccines. To overcome this, an MVAtor vector expressing three H5HA antigens A/Vietnam/1203/04, A/Indonesia/669/06 and A/Anhui/01/05 (MVAtor-tri-HA vector) was deve...
Main Authors: | Mookkan Prabakaran, Sonja Leyrer, Fang He, Sebastian Auer, Subaschandrabose R Kumar, Kathrin Kindsmueller, Nutan Mytle, Joerg Schneider, Stephen Lockhart, Jimmy Kwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4167863?pdf=render |
Similar Items
-
A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.
by: Nicholas W Florek, et al.
Published: (2017-01-01) -
Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.
by: Balraj Premanand, et al.
Published: (2013-01-01) -
Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes
by: Subaschandrabose Rajesh Kumar, et al.
Published: (2017-12-01) -
Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model
by: Justin G. Julander, et al.
Published: (2018-08-01) -
Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
by: César López-Camacho, et al.
Published: (2019-11-01)